(Q44101074)

29 November 2017

Rifampicin microparticles production by supercritical antisolvent precipitation (English)

1 reference

29 November 2017

1 reference

Ernesto Reverchon

1

1 reference

29 November 2017

Iolanda De Marco

series ordinal

2

1 reference

29 November 2017

Giovanna Della Porta

series ordinal

3

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 August 2002

1 reference

International Journal of Pharmaceutics

29 November 2017

1 reference

29 November 2017

243

1 reference

29 November 2017

1-2

1 reference

29 November 2017

83-91

1 reference

Production of griseofulvin nanoparticles using supercritical CO(2) antisolvent with enhanced mass transfer.

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

Rifamycin resistance in mycobacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

Determination of rifampin in human plasma by high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

Supercritical antisolvent micronization of some biopolymers

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

A critical review of the probable reasons for the poor variable bioavailability of rifampicin from anti-tubercular fixed-dose combination (FDC) products, and the likely solutions to the problem

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

Preparation and characterisation of hydrocortisone particles using a supercritical fluids extraction process.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

Formation of microparticulate protein powder using a supercritical fluid antisolvent.

1 reference

https://api.crossref.org/works/10.1016%2FS0378-5173%2802%2900261-2

7 January 2021

10.1016/S0378-5173(02)00261-2

Identifiers

DOI

1 reference

29 November 2017

1 reference